8-K: DarioHealth Acquires Twill, Creating Digital Health Powerhouse; Secures $22.4 Million in Financing

DarioHealth Corp. has acquired Twill, Inc., creating a comprehensive digital health platform and securing $22.4 million in a concurrent private placement.

Summary

• DarioHealth Corp. has acquired Twill, Inc., a move expected to nearly double Darios pro forma 2023 revenue.
• The combined company anticipates gross margins of 80-85% by 2025 and expects to reach profitability within two years post-acquisition.
• The acquisition is expected to drive higher enrollment and revenue per user through a broader product offering and improved navigation.
• Dario secured $22.4 million in a private placement of convertible preferred stock, with conversion prices of $2.02 and $2.14.
• The preferred stock includes a 7.5% dividend payable in common stock each quarter for the first four quarters, followed by a 15% stock dividend in the fifth quarter.
• The company will issue inducement grants of stock options to Twill employees, including 1,017,947 shares to Tomer Ben-Kiki, the new COO.

Sentiment

Score: 9

Explanation: The document is highly positive, highlighting a strategic acquisition, strong financial projections, and a clear path to profitability. The language used is very optimistic and forward-looking, suggesting a high level of confidence in the combined company's future.

Positives

• The acquisition creates a comprehensive multi-condition platform, addressing a larger market.
• The combined company is expected to have a SaaS-like financial profile with high growth potential.
• The acquisition is expected to improve client economics and drive higher revenue per user.
• The company expects to achieve significant cost synergies and accelerate its path to profitability.
• The strategic partnership with Sanofi is expected to accelerate commercial adoption and drive expansion of digital health solutions.

Risks

• The company's ability to integrate Twill and its operations may impact the expected synergies.
• The company's ability to achieve the projected revenue growth and profitability may be affected by market conditions and competition.
• The company's ability to obtain stockholder approval for the issuance of shares related to the acquisition may be delayed or not obtained.

Future Outlook

The company expects to accelerate market penetration, drive higher revenue per user, and reach profitability within the second year post-acquisition.

Management Comments

• The acquisition of Twill is an incredible opportunity to bring together our complementary solutions and create an unrivaled platform for the next generation of consumer-centric digital health, said Erez Raphael, CEO of Dario.
• It's not just a goal, it's a pathway, said Tomer Ben-Kiki, Twills Co-Founder and CEO. This shared vision fuels our powerful union, transforming data into a vibrant tapestry of individual health stories.

Industry Context

The acquisition reflects a trend in the digital health industry towards consolidation and the creation of comprehensive platforms that address multiple chronic conditions. The combination of Dario and Twill positions the company to compete more effectively in a market that is increasingly demanding integrated solutions.

Comparison to Industry Standards

• The combined company will have a broader product offering than many point solutions in the digital health market, which often focus on a single condition.
• The expected gross margins of 80-85% are higher than many traditional healthcare companies and are more in line with SaaS companies.
• The company's focus on a consumer-centric approach and AI-driven navigation is consistent with the trend towards personalized and engaging digital health solutions.
• The company's strategic partnerships with major health plans and pharmaceutical companies are comparable to other leading digital health companies.

Management Changes

Stakeholder Impact

• Shareholders are expected to benefit from the increased revenue, profitability, and market position of the combined company.
• Employees of both companies will be integrated into a larger organization with expanded opportunities.
• Customers will have access to a more comprehensive suite of digital health solutions.
• Partners will benefit from the expanded reach and capabilities of the combined platform.

Next Steps

• The company will integrate Twill and its operations.
• The company will seek stockholder approval for the issuance of shares related to the acquisition.
• The company will continue to pursue strategic partnerships and expand its customer base.

Key Dates

Keywords

digital health, chronic conditions, acquisition, merger, private placement, convertible preferred stock, digital therapeutics, SaaS, gross margins, profitability, Twill, DarioHealth, AI, navigation, GLP-1, Sanofi, multi-condition